Table 5.
Influence of participant’s attitudes, knowledge, and experience on preferences toward in-person GC model and duration
| Preferences toward pretest GC model | Preferences toward pretest GC duration (minutes in length) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n = 110a | In-person GC (n = 92) | Classroom or group GC (n = 15) | n = 112b | ≥30c (n = 33) | <15 (n = 17) | |||||
| Number | Number (%) | p value | Number (%) | p value | Number | Number (%) | p value | Number (%) | p value | |
| Experience | ||||||||||
| Prenatal testing in a prior pregnancy | 0.050 | 0.959 | 0.363 | 0.946 | ||||||
| Yes | 7 | 4/7 (57.1) | 1/7 (14.3) | 7 | 1/7 (14.3) | 1/7 (14.3) | ||||
| No | 103 | 88/103 (85.4) | 14/103 (13.6) | 105 | 32/105 (30.5) | 16/105 (15.2) | ||||
| Had someone in their vicinity with T21 or talked with people of T21 | 0.837 | 0.853 | 0.017 | 0.289 | ||||||
| Yes | 39 | 33/39 (84.6) | 5/39 (12.8) | 39 | 17/39 (43.6) | 4/39 (10.3) | ||||
| No | 71 | 59/71 (83.1) | 10/71 (14.1) | 73 | 16/73 (21.9) | 13/73 (17.8) | ||||
| Prenatal testing in this pregnancy | 0.587 | 0.417 | 0.328 | 0.099 | ||||||
| None | 62 | 50/62 (80.7) | 10/62 (16.1) | 64 | 21/64 (32.8) | 8/64 (12.5) | ||||
| NIPT | 25 | 23/25 (92.0) | 1/25 (4.0) | 25 | 4/25 (16.0) | 2/25 (8.0) | ||||
| MSS | 22 | 18/22 (81.8) | 4/22 (18.2) | 22 | 8/22 (36.4) | 7/22 (31.8) | ||||
| AC/CVS | 1 | 1/1 (100.0) | 0/4 (0.0) | 1 | 0/1 (0.0) | 0/1 (0.0) | ||||
| Attitudes | ||||||||||
| Preference on brochures of prenatal testing at the first visit | 0.687 | 0.645 | 0.476 | 0.763 | ||||||
| Wanted to receive | 75 | 62/75 (85.7) | 11/75 (14.7) | 76 | 24/76 (31.6) | 11/76 (14.5) | ||||
| No or neither or don’t know | 35 | 30/35 (82.7) | 4/35 (11.4) | 36 | 9/36 (25.0) | 6/36 (16.7) | ||||
| Planned prenatal testing at questionnaire | 0.157 | 0.292 | 0.561 | 0.790 | ||||||
| No testing | 32 | 25/32 (78.1) | 6/32 (18.8) | 33 | 11 /33 (33.3) | 6 /33 (18.2) | ||||
| Undecided | 33 | 31/33 (93.9) | 2/33 (6.1) | 33 | 11/33 (33.3) | 4/33 (12.1) | ||||
| Will have testing | 45 | 36/45 (80.0) | 7/45 (15.6) | 46 | 11/46 (23.9) | 7/46 (15.2) | ||||
| Needed agreement with the partner for prenatal testing | 0.229 | 0.028 | 0.855 | 0.043 | ||||||
| Yes | 86 | 70/86 (81.4) | 15/86 (17.4) | 87 | 26/87 (29.9) | 10/87 (11.5) | ||||
| No or neither or don’t know | 24 | 22/24 (91.7) | 0/24 (0.0) | 25 | 7 /25 (28.0) | 7 /25 (28.0) | ||||
| Want to have GC with husband | 0.744 | 0.725 | 0.157 | 0.171 | ||||||
| Yes | 100 | 84/100 (84.0) | 14/100 (14.0) | 102 | 32/102 (31.4) | 14/102 (13.7) | ||||
| No | 10 | 8/10 (80.0) | 1/10 (10.0) | 10 | 1/10 (10.0) | 3/10 (30.0) | ||||
| Knowledge | ||||||||||
| Aware of prenatal testing before this pregnancy | 0.275 | 0.397 | 0.037 | 0.183 | ||||||
| Yes | 95 | 78/95 (82.1) | 14/95 (14.7) | 97 | 32/97 (33.0) | 13/97 (13.4) | ||||
| No | 15 | 14/15 (93.3) | 1/15 (6.7) | 15 | 1/15 (6.7) | 4/15 (26.7) | ||||
| Aware of GC | 0.877 | 0.312 | 0.140 | 0.056 | ||||||
| Yes | 26 | 22/26 (84.6) | 2/26 (7.7) | 27 | 11/27 (40.7) | 1/27 (3.7) | ||||
| No | 84 | 70/84 (83.3) | 13/84 (15.5) | 85 | 22/85 (25.9) | 16/85 (18.8) | ||||
| Understanding of mechanism of T21 | 0.933 | 0.724 | 0.617 | 0.054 | ||||||
| Not an inherited disease | 56 | 47/56 (83.9) | 7/56 (12.5) | 57 | 18/57 (31.6) | 5/57 (8.8) | ||||
| Inherited disease or don’t know | 54 | 45/54 (83.3) | 8/54 (14.8) | 55 | 15/55 (27.3) | 12/55 (21.8) | ||||
| Understanding of average of life expectancy of T21 | 0.425 | 0.200 | 0.629 | 0.027 | ||||||
| ≥40 years old | 46 | 40/46 (87.0) | 4/46 (8.7) | 47 | 15/47 (31.9) | 3/47 (6.4) | ||||
| <40 years old or don’t know | 64 | 52/64 (81.3) | 11/64 (17.8) | 65 | 18/65 (27.7) | 14/65 (21.5) | ||||
| Recognition of MAE-related disorders | 0.194 | 0.243 | 0.208 | 0.723 | ||||||
| Yes | 102 | 84/102 (82.4) | 15/102 (14.7) | 103 | 32/103 (31.1) | 16/103 (15.5) | ||||
| No | 8 | 8/8(100.0) | 0/8 (0.0) | 9 | 1/9 (11.1) | 1/9 (11.1) | ||||
AC amniocentesis, CVS chorionic villus sampling, GC genetic counseling, NIPT noninvasive prenatal testing, MSS maternal serum screening, MAE maternal age effect, T21 trisomy 21
aFour participants who answered “don’t know” to the questions about preference for GC models were excluded from this analysis
bTwo participants who answered “don’t know” to the questions about preference for duration of pretest GC time were excluded from this analysis
cIncludes participants who preferred 30–59 min only, as no participants preferred ≥60 min